Company intelligence / Profile preview
Tabros Pharma
- Ownership
- Private
- Development stage
- Commercial
Overview
Tabros Pharma has a long-standing presence since its establishment in 1971. It produces high-quality pharmaceutical products under cGMP standards. The company ranks among the top national pharmaceutical companies in Pakistan with a diverse portfolio of generic medicines including tablets, sachets for oral rehydration salts, and topical creams. It emphasizes quality manufacturing and international expansion into East Africa, Southeast Asia, Far East and CIS countries.
- Therapeutic areas
- OtherInfectious DiseasesImmunologyHematology
- Modalities
- Small molecules (generic pharmaceuticals and drug formulations)Oral solid dosage forms and topical creams/ointments indicated by product examples like tablets and creams
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Tabros Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tabros Pharma.